AAAAAA

   
Results: 1-22 |
Results: 22
NEW THERAPEUTIC AGENTS OF POTENTIAL USE IN ACUTE MYELOID-LEUKEMIA
Authors: GREVER M
Citation: M. Grever, NEW THERAPEUTIC AGENTS OF POTENTIAL USE IN ACUTE MYELOID-LEUKEMIA, Leukemia & lymphoma (Print), 30, 1998, pp. 35-36
IDENTIFICATION OF COMPOUNDS WITH PREFERENTIAL INHIBITORY ACTIVITY AGAINST LOW-NM23-EXPRESSING HUMAN BREAST-CARCINOMA AND MELANOMA CELL-LINES
Authors: FREIJE JMP LAWRENCE JA HOLLINGSHEAD MG DELAROSA A NARAYANAN V GREVER M SAUSVILLE EA PAULL K STEEG PS
Citation: Jmp. Freije et al., IDENTIFICATION OF COMPOUNDS WITH PREFERENTIAL INHIBITORY ACTIVITY AGAINST LOW-NM23-EXPRESSING HUMAN BREAST-CARCINOMA AND MELANOMA CELL-LINES, Nature medicine, 3(4), 1997, pp. 395-401
FLAVOPIRIDOL (L86-8275) - SELECTIVE ANTITUMOR-ACTIVITY IN-VITRO AND ACTIVITY IN-VIVO FOR PROSTATE CARCINOMA-CELLS
Authors: DREES M DENGLER WA ROTH T LABONTE H MAYO J MALSPEIS L GREVER M SAUSVILLE EA FIEBIG HH
Citation: M. Drees et al., FLAVOPIRIDOL (L86-8275) - SELECTIVE ANTITUMOR-ACTIVITY IN-VITRO AND ACTIVITY IN-VIVO FOR PROSTATE CARCINOMA-CELLS, Clinical cancer research, 3(2), 1997, pp. 273-279
USING ENGINEERED ALLOGRAFTS TO IMPROVE TRANSPLANT OUTCOME IN MULTIPLE-MYELOMA (MM)
Authors: NOGA SJ ODONNELL PV GREVER M VOGELSANG GB MARCELLUS D JONES RJ
Citation: Sj. Noga et al., USING ENGINEERED ALLOGRAFTS TO IMPROVE TRANSPLANT OUTCOME IN MULTIPLE-MYELOMA (MM), Blood, 90(10), 1997, pp. 992-992
USING ENGINEERED ALLOGRAFTS TO IMPROVE TRANSPLANT OUTCOME IN MYELODYSPLASTIC SYNDROME (MDS)
Authors: ODONNELL PV NOGA SJ GREVER M VOGELSANG GB JONES RJ
Citation: Pv. Odonnell et al., USING ENGINEERED ALLOGRAFTS TO IMPROVE TRANSPLANT OUTCOME IN MYELODYSPLASTIC SYNDROME (MDS), Blood, 90(10), 1997, pp. 1009-1009
INTERLEUKIN-4 INDUCES RESISTANCE TO F-ARA-A AND UCN-01, BUT NOT FLAVOPIRIDOL IN A BCL-2 INDEPENDENT MANNER
Authors: BYRD JC WASELENKO JK SHINN CA FLINN IW DIEHL LF GREVER M
Citation: Jc. Byrd et al., INTERLEUKIN-4 INDUCES RESISTANCE TO F-ARA-A AND UCN-01, BUT NOT FLAVOPIRIDOL IN A BCL-2 INDEPENDENT MANNER, Blood, 90(10), 1997, pp. 2368-2368
LONG-TERM RESULTS IN HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN
Authors: FLINN IW KOPECKY KJ FOUCAR MK HEAD D BENNETT JM HUTCHISON RE CORBETT WEN CASSILETH PA HABERMANN T GOLOMB H RAI K EISENHAUER E APPELBAUM FR CHESON BD GREVER M
Citation: Iw. Flinn et al., LONG-TERM RESULTS IN HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN, Blood, 90(10), 1997, pp. 2575-2575
REDUCTASE ENZYME EXPRESSION ACROSS THE NATIONAL-CANCER-INSTITUTE TUMOR-CELL LINE PANEL - CORRELATION WITH SENSITIVITY TO MITOMYCIN-C AND E09
Authors: FITZSIMMONS SA WORKMAN P GREVER M PAULL K CAMALIER R LEWIS AD
Citation: Sa. Fitzsimmons et al., REDUCTASE ENZYME EXPRESSION ACROSS THE NATIONAL-CANCER-INSTITUTE TUMOR-CELL LINE PANEL - CORRELATION WITH SENSITIVITY TO MITOMYCIN-C AND E09, Journal of the National Cancer Institute, 88(5), 1996, pp. 259-269
REDUCTASE ENZYME EXPRESSION ACROSS THE NATIONAL-CANCER-INSTITUTE TUMOR-CELL LINE PANEL - CORRELATION WITH SENSITIVITY TO MITOMYCIN-C AND EO9 - RESPONSE
Authors: WORKMAN P FITZSIMMONS SA GREVER M PAULL K CAMALIER R LEWIS AD
Citation: P. Workman et al., REDUCTASE ENZYME EXPRESSION ACROSS THE NATIONAL-CANCER-INSTITUTE TUMOR-CELL LINE PANEL - CORRELATION WITH SENSITIVITY TO MITOMYCIN-C AND EO9 - RESPONSE, Journal of the National Cancer Institute, 88(16), 1996, pp. 1161-1163
A RANDOMIZED INVESTIGATION OF HIGH-DOSE VERSUS STANDARD-DOSE CYTOSINE-ARABINOSIDE WITH DAUNORUBICIN IN PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: WEICK JK KOPECKY KJ APPELBAUM FR HEAD DR KINGSBURY LL BALCERZAK SP BICKERS JN HYNES HE WELBORN JL SIMON SR GREVER M
Citation: Jk. Weick et al., A RANDOMIZED INVESTIGATION OF HIGH-DOSE VERSUS STANDARD-DOSE CYTOSINE-ARABINOSIDE WITH DAUNORUBICIN IN PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Blood, 88(8), 1996, pp. 2841-2851
IMPROVED HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML) FOLLOWING ADMINISTRATION OF THE PUTATIVE DIFFERENTIATING AGENT SODIUM PHENYLBURYRATE (SPB)
Authors: GORE SD MILLER CB WENG LJ BURKS K GRIFFIN CA CHEN TL BURKE PJ GREVER M ROWINSKY EK
Citation: Sd. Gore et al., IMPROVED HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML) FOLLOWING ADMINISTRATION OF THE PUTATIVE DIFFERENTIATING AGENT SODIUM PHENYLBURYRATE (SPB), Blood, 88(10), 1996, pp. 2315-2315
RANDOMIZED COMPARISON OF PENTOSTATIN VERSUS INTERFERON ALFA-2A IN PREVIOUSLY UNTREATED PATIENTS WITH HAIRY-CELL LEUKEMIA - AN INTERGROUP STUDY
Authors: GREVER M KOPECKY K FOUCAR MK HEAD D BENNETT JM HUTCHISON RE CORBETT WEN CASSILETH PA HABERMANN T GOLOMB H RAI K EISENHAUER E APPELBAUM F CHESON BD
Citation: M. Grever et al., RANDOMIZED COMPARISON OF PENTOSTATIN VERSUS INTERFERON ALFA-2A IN PREVIOUSLY UNTREATED PATIENTS WITH HAIRY-CELL LEUKEMIA - AN INTERGROUP STUDY, Journal of clinical oncology, 13(4), 1995, pp. 974-982
OPTIMAL TREATMENT FOR UNTREATED PATIENTS WITH HAIRY-CELL LEUKEMIA - REPLY
Authors: GREVER M KOPECKY K APPELBAUM F FOUCAR MK
Citation: M. Grever et al., OPTIMAL TREATMENT FOR UNTREATED PATIENTS WITH HAIRY-CELL LEUKEMIA - REPLY, Journal of clinical oncology, 13(10), 1995, pp. 2678-2679
TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS OVER 50 YEARS OF AGE WITH V-TAD - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: BIGELOW CL KOPECKY K FILES JC HEAD D LIPSCHITZ DA GREVER M APPELBAUM FR
Citation: Cl. Bigelow et al., TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS OVER 50 YEARS OF AGE WITH V-TAD - A SOUTHWEST-ONCOLOGY-GROUP STUDY, American journal of hematology, 48(4), 1995, pp. 228-232
IN-VIVO DRUG SCREENING APPLICATIONS OF HIV-INFECTED CELLS CULTIVATED WITHIN HOLLOW FIBERS IN 2 PHYSIOLOGICAL COMPARTMENTS OF MICE
Authors: HOLLINGSHEAD M ROBERSON J DECKER W BUCKHEIT R ELDER C MALSPEIS L MAYO J GREVER M
Citation: M. Hollingshead et al., IN-VIVO DRUG SCREENING APPLICATIONS OF HIV-INFECTED CELLS CULTIVATED WITHIN HOLLOW FIBERS IN 2 PHYSIOLOGICAL COMPARTMENTS OF MICE, Antiviral research, 28(3), 1995, pp. 265-279
THE SEX OF KNOWLEDGE - WOMEN AND HIGHER-E DUCATION IN THE NETHERLANDS, 1878-1948 - DUTCH - BOSCH,M
Authors: GREVER M
Citation: M. Grever, THE SEX OF KNOWLEDGE - WOMEN AND HIGHER-E DUCATION IN THE NETHERLANDS, 1878-1948 - DUTCH - BOSCH,M, Tijdschrift voor geschiedenis, 108(3), 1995, pp. 421-423
GENERATION OF A DRUG-RESISTANCE PROFILE BY QUANTITATION OF MDR-1 P-GLYCOPROTEIN IN THE CELL-LINES OF THE NATIONAL-CANCER-INSTITUTE ANTICANCER DRUG SCREEN/
Authors: ALVAREZ M PAULL K MONKS A HOSE C LEE JS WEINSTEIN J GREVER M BATES S FOJO T
Citation: M. Alvarez et al., GENERATION OF A DRUG-RESISTANCE PROFILE BY QUANTITATION OF MDR-1 P-GLYCOPROTEIN IN THE CELL-LINES OF THE NATIONAL-CANCER-INSTITUTE ANTICANCER DRUG SCREEN/, The Journal of clinical investigation, 95(5), 1995, pp. 2205-2214
MINIMAL RESIDUAL DISEASE IN PATIENTS WITH HAIRY-CELL LEUKEMIA IN COMPLETE REMISSION - COMPARISON OF 2-CHLORODEOXYADENOSINE WITH 2-DEOXYCOFORMYCIN AND PREDICTION OF EARLY RELAPSE
Authors: TALLMAN M HAKIMIAN D WHEATON S KOPECKY K WOLLINS E FOUCAR K CASSILETH P HABERMANN T GREVER M PETERSON LC
Citation: M. Tallman et al., MINIMAL RESIDUAL DISEASE IN PATIENTS WITH HAIRY-CELL LEUKEMIA IN COMPLETE REMISSION - COMPARISON OF 2-CHLORODEOXYADENOSINE WITH 2-DEOXYCOFORMYCIN AND PREDICTION OF EARLY RELAPSE, Blood, 86(10), 1995, pp. 1390-1390
WRITING WOMENS HISTORY - INTERNATIONAL PE RSPECTIVES - OFFEN,K, ROACHPIERSON,R, RENDALL,J
Authors: GREVER M
Citation: M. Grever, WRITING WOMENS HISTORY - INTERNATIONAL PE RSPECTIVES - OFFEN,K, ROACHPIERSON,R, RENDALL,J, Tijdschrift voor geschiedenis, 107(1), 1994, pp. 69-70
RHODAMINE EFFLUX PATTERNS PREDICT P-GLYCOPROTEIN SUBSTRATES IN THE NATIONAL-CANCER-INSTITUTE DRUG SCREEN
Authors: LEE JS PAULL K ALVAREZ M HOSE C MONKS A GREVER M FOJO AT BATES SE
Citation: Js. Lee et al., RHODAMINE EFFLUX PATTERNS PREDICT P-GLYCOPROTEIN SUBSTRATES IN THE NATIONAL-CANCER-INSTITUTE DRUG SCREEN, Molecular pharmacology, 46(4), 1994, pp. 627-638
NEW CHEMOTHERAPEUTIC-AGENTS IN NON-SMALL-CELL LUNG-CANCER
Authors: FEIGAL EG CHRISTIAN M CHESON B GREVER M FRIEDMAN MA
Citation: Eg. Feigal et al., NEW CHEMOTHERAPEUTIC-AGENTS IN NON-SMALL-CELL LUNG-CANCER, Seminars in oncology, 20(2), 1993, pp. 185-201
A RANDOMIZED COMPARISON OF DEOXYCOFORMYCIN (DCF) VERSUS ALPHA-2A INTERFERON (IFN) IN PREVIOUSLY UNTREATED PATIENTS (PTS) WITH HAIRY-CELL LEUKEMIA (HCL) - AN UPDATED REPORT ON THE NCI-SPONSORED INTERGROUP STUDY(SWOG, ECOG, CALGB, NCIC CTG)
Authors: GREVER M KOPECKY K HEAD D FOUCAR K CASSILETH P GOLOMB H HABERMANN T RAI K EISENHAUER E APPELBAUM F CHESON B
Citation: M. Grever et al., A RANDOMIZED COMPARISON OF DEOXYCOFORMYCIN (DCF) VERSUS ALPHA-2A INTERFERON (IFN) IN PREVIOUSLY UNTREATED PATIENTS (PTS) WITH HAIRY-CELL LEUKEMIA (HCL) - AN UPDATED REPORT ON THE NCI-SPONSORED INTERGROUP STUDY(SWOG, ECOG, CALGB, NCIC CTG), Blood, 82(10), 1993, pp. 10000199-10000199
Risultati: 1-22 |